Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
出版年份 2021 全文链接
标题
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
作者
关键词
-
出版物
Blood Advances
Volume 5, Issue 9, Pages 2375-2384
出版商
American Society of Hematology
发表日期
2021-05-04
DOI
10.1182/bloodadvances.2021004467
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial
- (2020) Heiko Schöder et al. BLOOD
- Interim PET evaluation in diffuse large B-cell lymphoma employing published recommendations: Comparison of the Deauville 5-point scale and the ΔSUVmax method
- (2020) Jan Rekowski et al. JOURNAL OF NUCLEAR MEDICINE
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
- (2020) Pieternella Johanna Lugtenburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001
- (2020) Daniel O. Persky et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim positron emission tomography in diffuse large B-cell lymphoma
- (2020) Lars Kurch et al. JOURNAL OF NUCLEAR MEDICINE
- Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden
- (2019) Sally F. Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients
- (2019) Renata Nyilas et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome
- (2019) Anne-Segolene Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Combined Visual and Semi-quantitative Evaluation Improves Outcome Prediction by Early Mid-treatment 18F-fluoro-deoxi-glucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
- (2019) Tamas Gyorke et al. JOURNAL OF NUCLEAR MEDICINE
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
- (2019) Christine Schmitz et al. EUROPEAN JOURNAL OF CANCER
- Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
- (2019) Viola Poeschel et al. LANCET
- Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
- (2018) M J Maurer et al. ANNALS OF ONCOLOGY
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2018) Coreline N. Burggraaff et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
- (2015) Christoph Mamot et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
- (2014) R. Carr et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
- (2014) Karen Juul Mylam et al. LEUKEMIA & LYMPHOMA
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma
- (2010) Pier Luigi Zinzani et al. CANCER
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started